Plaque Psoriasis Management: The New Era of Biologics
Plaque psoriasis affects roughly 2% of the population and carries substantial systemic burdens, including cardiovascular disease, psoriatic arthritis, metabolic syndrome, non-alcoholic fatty liver disease, and depression. Contemporary reviews and meta-analyses consistently link psoriasis to increased cardiovascular events, leading major medical societies to classify the skin condition as a cardiovascular risk enhancer that requires aggressive risk-factor … Read more